Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0354719930170040395
Journal of Korean Diabetes Association
1993 Volume.17 No. 4 p.395 ~ p.402
Effect of Cisapride on Diabetic Gastroparesis
±è¹Î¼±
Á¤ÀçÈÆ/¹Ú¿ë¼ö/¹Ú°æ¼ö/±è¼º¿¬/À̸íö/Á¶º¸¿¬/ÀÌÈ«±Ô/°íâ¼ø
Abstract
Background:
@EN Diabetic gastroparesis is a common diabetic autonomic neuropathy and is characterized by epigastric discomfort, abdominal pain, intractable nausea and vomiting and so on. None of various agents has been demonstrated the long-term efficacy in
patients with diabetic gastroparesis. Recently, it has been reported that Cisapride, a new prokinetic agent, promotes gastric emptying through direct action on myenteric plexus by releasing acetylcholin. Therefore, we evaluated the long-term
effect
of
cisapride on gastric emptying of solid meals in patients with symptomatic diabetic gastroparesis.
@ES Methods:
@EN We conducted a 4-week trial of cisapride (10§· t.i.d) in 10 diabetic patients with severe upper gastrointestinal symptoms (symptom score>5) and delayed gastric emptying in gastric emtying time (GET) scan. The symptom scores were assessed at
the
entry. Midperiod and at the end of the 40-week period. The changes of gastric emptying time were also evaluated before and after trial. We also evaluated gastric emptying time in 10 normal persons and 10 diabetic patients without gastrointestinal
symptoms to identify whether delayed gastric emptying is detected in diabetic patients regardless of the presence of symptoms.
@ES Results:
@EN 1) Nine of 10 diabetic patients with severe symptoms experienced symptomatic improvement and 8 patients of them were improved within 2 weeks after trial of cisapride.
2) Gastric remaining radioactivities at 90 min were significantly decreased in 10 diabetic patients (before treatment 54.1¡¾1.77%; after treatment 29.5¡¾2.83%, p<0.05). However, 4 of 10 patients were not improved at the end of 4-week trial and 3
patients of them had severe other autonomic neuropathy.
3) There was no difference in gastric emptying time between normal persons and asypmtomatic diabetic patient with orthostatic hypotension had delayed gastric emptying (T1/2=100 min).
4) There was no remarkable side effect during cisa-pride trial.
@ES Conclusion :
@EN We experienced improvement of symptoms and delayed gastric emptying in diabetic patients with severe gastroparesis after 4-week trial of cisapride. Most of asymptomatic diabetic patients has no delayed gastric emptying in GET scan.
KEYWORD
FullTexts / Linksout information
Listed journal information
KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø